Intravitreal Bevacizumab (Avastin) and Panretinal Photocoagulation in the Treatment of High-Risk Proliferative Diabetic Retinopathy

PURPOSE: To report the short-term efficacy and safety of intravitreal bevacizumab (Avastin) injection with panretinal laser photocoagulation (PRP) in patients with high-risk proliferative diabetic retinopathy (PDR) according to the Early Treatment Diabetic Retinopathy Study criteria. METHODS: A pros...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Yang, Chang-Sue, Hung, Kuo-Che, Huang, Yi-Ming, Hsu, Wen-Ming
Médium: Artigo
Jazyk:Inglês
Vydáno: Mary Ann Liebert, Inc. 2013
Témata:
Original Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3708621/
https://ncbi.nlm.nih.gov/pubmed/23495932
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/jop.2012.0202
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky